Marco Colleoni
Marco Colleoni
Direttore, Divisione di Senologia Medica, Istituto Europeo di Oncologia, Milano
Email verificata su ieo.it
Titolo
Citata da
Citata da
Anno
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ...
Annals of oncology 24 (9), 2206-2223, 2013
27402013
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ...
Annals of oncology 26 (8), 1533-1546, 2015
15132015
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98
AS Coates, A Keshaviah, B Thurlimann, H Mouridsen, L Mauriac, ...
Journal of clinical oncology 25 (5), 486-492, 2007
10202007
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous …
M Cristofanilli, NC Turner, I Bondarenko, J Ro, SA Im, N Masuda, ...
The Lancet Oncology 17 (4), 425-439, 2016
9652016
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial
V Galimberti, BF Cole, S Zurrida, G Viale, A Luini, P Veronesi, P Baratella, ...
The lancet oncology 14 (4), 297-305, 2013
9032013
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen
M Dowsett, J Cuzick, J Ingle, A Coates, J Forbes, J Bliss, M Buyse, ...
Journal of Clinical Oncology 28 (3), 509-518, 2010
8732010
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer
O Pagani, MM Regan, BA Walley, GF Fleming, M Colleoni, I Láng, ...
New England Journal of Medicine 371 (2), 107-118, 2014
6682014
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 386 (10001), 1341-1352, 2015
6572015
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G Curigliano, HJ Burstein, E P Winer, M Gnant, P Dubsky, S Loibl, ...
Annals of Oncology 28 (8), 1700-1712, 2017
6352017
Adjuvant ovarian suppression in premenopausal breast cancer
PA Francis, MM Regan, GF Fleming, I Láng, E Ciruelos, M Bellet, ...
New England Journal of Medicine 372 (5), 436-446, 2015
6092015
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels
M Colleoni, A Rocca, MT Sandri, L Zorzino, G Masci, F Nole, G Peruzzotti, ...
Annals of Oncology 13 (1), 73-80, 2002
5072002
Very young women (< 35 years) with operable breast cancer: features of disease at presentation
M Colleoni, N Rotmensz, C Robertson, L Orlando, G Viale, G Renne, ...
Annals of Oncology 13 (2), 273-279, 2002
4652002
Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents
Y Shaked, E Henke, JML Roodhart, P Mancuso, MHG Langenberg, ...
Cancer cell 14 (3), 263-273, 2008
4632008
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment
M Colleoni, G Viale, D Zahrieh, G Pruneri, O Gentilini, P Veronesi, ...
Clinical Cancer Research 10 (19), 6622-6628, 2004
4102004
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
M Kaufmann, G Von Minckwitz, HD Bear, A Buzdar, P McGale, H Bonnefoi, ...
Annals of Oncology 18 (12), 1927-1934, 2007
3952007
International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?
O Pagani, E Senkus, W Wood, M Colleoni, T Cufer, S Kyriakides, A Costa, ...
Journal of the National Cancer Institute 102 (7), 456-463, 2010
3442010
Overall survival with palbociclib and fulvestrant in advanced breast cancer
NC Turner, DJ Slamon, J Ro, I Bondarenko, SA Im, N Masuda, M Colleoni, ...
New England Journal of Medicine 379 (20), 1926-1936, 2018
3312018
Depression and degree of acceptance of adjuvant cytotoxic drugs
M Colleoni, M Mandala, G Peruzzotti, C Robertson, A Bredart, ...
The Lancet 356 (9238), 1326-1327, 2000
3312000
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
D Tripathy, SA Im, M Colleoni, F Franke, A Bardia, N Harbeck, SA Hurvitz, ...
The lancet oncology 19 (7), 904-915, 2018
3072018
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer
S Dellapasqua, F Bertolini, V Bagnardi, E Campagnoli, E Scarano, ...
Journal of Clinical Oncology 26 (30), 4899-4905, 2008
3052008
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20